[1]Patent:WO2009/106577,2009,A1,.Locationinpatent:Page/Pagecolumn77-78
Title: A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients.
Journal: Cancer research 20110801